A novel biomarker for mutant p53 could help pathologists assessing tumors during surgery

Originally posted on MEDIC FINDER:
Cold Spring Harbor, NY — Researchers at Cold Spring Harbor Laboratory (CSHL) today report the discovery of a novel cellular biomarker that could make it comparatively easy for cancer surgeons to determine if a patient has a potentially lethal mutation in a protein called p53, the most powerful o… A…

Read more "A novel biomarker for mutant p53 could help pathologists assessing tumors during surgery"